智通财经APP获悉，方舟健客(06086)最高涨超11%，截至发稿，涨7.26%，报4.43港元，成交额5393.17万港元。
消息面上，近日，方舟健客亮相2025大湾区肝病国际论坛，在肝炎早防早治项目推进会上，广东省肝脏疾病研究所授予方舟健客“AI+病毒性肝炎防治联合培训基地”牌匾，双方携手共同聚焦“AI+肝病全生命周期管理”领域，以AI技术赋能肝病防治。据方舟健客上市后首份年报，该公司全年实现营收27.07亿元，同比增长11.2%；而经调整后的净利润为1711.9万元，同比增长139%。注册用户增长650万名，达4920万名；月活用户同比增长20%，达1010万名，领跑互联网慢病管理垂直细分领域。
据悉，方舟健客计划于2025年聚焦多个“AI智能助理”场景开发，推动应用落地。公司将加大研发投入，借助deepseek等先进大模型，挖掘医疗数据价值，为医药行业打造专属“数字员工”和“智能体解决方案”，推动互联网医疗向更专业、高效、智能方向发展。华泰证券认为，AI正在构建医疗新范式，AI医疗2025年大有可为，该行强调2025年“AI+医疗”将迎来跨越式发展，应重视相关投资机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.